Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 18 May 2006. doi:10.1136/hrt.2005.085530
Heart 2006;92:1645-1650
Copyright © 2006 BMJ Publishing Group Ltd & British Cardiovascular Society

CARDIOVASCULAR MEDICINE

Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients

J Dernellis, M Panaretou

Department of Cardiology, Vostanion Hospital, Mytilini, Greece

Correspondence to:
Dr John Dernellis
1 Kathigitou Karakatsani St, 811 00 Mytilini, Greece; dernellis{at}yahoo.gr

Objective: To evaluate the predictive value of brain natriuretic peptide (BNP) for assessment of cardiac risk before non-cardiac surgery.

Methods: Consecutively treated patients (947 men, 643 women) whose BNP was measured before non-cardiac surgery were studied. Clinical and ECG variables were evaluated to identify predictors of postoperative cardiac events.

Results: Events occurred in 6% of patients: 21 cardiac deaths, 20 non-fatal myocardial infarctions, 41 episodes of pulmonary oedema and 14 patients with ventricular tachycardia. All of these patients had raised plasma BNP concentrations (best cut-off point 189 pg/ml). The only independent predictor of postoperative events was BNP (odds ratio 34.52, 95% confidence interval (CI) 17.08 to 68.62, p < 0.0001). Clinical variables of Goldman’s multifactorial index identified 18% of patients in class I, 40% in class II, 24% in class III and 18% in class IV preoperatively; postoperative event rates were 2%, 3%, 7% and 14%, respectively. BNP identified 60% of patients as having zero risk (BNP 0–100 pg/ml), 22% low risk (101–200 pg/ml), 14% intermediate risk (201–300 pg/ml) and 4% high risk (> 300 pg/ml); postoperative event rates were 0%, 5%, 12% and 81%, respectively.

Conclusions: In this population of patients evaluated before non-cardiac surgery, BNP is an independent predictor of postoperative cardiac events. BNP > 189 pg/ml identified patients at highest risk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Goei, D., Flu, W.-J., Hoeks, S. E., Galal, W., Dunkelgrun, M., Boersma, E., Kuijper, R., van Kuijk, J.-P., Winkel, T. A., Schouten, O., Bax, J. J., Poldermans, D. (2009). The Interrelationship Between Preoperative Anemia and N-Terminal Pro-B-Type Natriuretic Peptide: The Effect on Predicting Postoperative Cardiac Outcome in Vascular Surgery Patients. Anesth. Analg. 109: 1403-1408 [Abstract] [Full Text]  
  • Karthikeyan, G., Moncur, R. A., Levine, O., Heels-Ansdell, D., Chan, M. T.V., Alonso-Coello, P., Yusuf, S., Sessler, D., Villar, J. C., Berwanger, O., McQueen, M., Mathew, A., Hill, S., Gibson, S., Berry, C., Yeh, H.-M., Devereaux, P.J. (2009). Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.. J Am Coll Cardiol 54: 1599-1606 [Abstract] [Full Text]  
  • Bolliger, D., Seeberger, M. D., Filipovic, M. (2009). Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet?. J Am Coll Cardiol 54: 1607-1608 [Full Text]  
  • Oscarsson, A., Fredrikson, M., Sorliden, M., Anskar, S., Eintrei, C. (2009). N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery. Br J Anaesth 103: 206-212 [Abstract] [Full Text]  
  • Bolliger, D., Seeberger, M. D., Lurati Buse, G. A. L., Christen, P., Rupinski, B., Gurke, L., Filipovic, M. (2009). A Preliminary Report on the Prognostic Significance of Preoperative Brain Natriuretic Peptide and Postoperative Cardiac Troponin in Patients Undergoing Major Vascular Surgery. Anesth. Analg. 108: 1069-1075 [Abstract] [Full Text]  
  • Fox, A. A., Shernan, S. K., Collard, C. D., Liu, K.-Y., Aranki, S. F., DeSantis, S. M., Jarolim, P., Body, S. C. (2008). Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.. J. Thorac. Cardiovasc. Surg. 136: 452-461 [Abstract] [Full Text]  
  • Mahla, E., Vicenzi, M., Toller, W., Cuthbertson, B. H., (on behalf of the authors), (2007). B-type natriuretic peptide in high-risk major surgery patients. Br J Anaesth 99: 746-747 [Full Text]  
  • Sear, J. W., Howard-Alpe, G. (2007). Preoperative plasma BNP concentrations: do they improve our care of high-risk non-cardiac surgical patients?. Br J Anaesth 99: 151-154 [Full Text]  
  • Struthers, A., Lang, C. (2007). The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J 28: 1678-1682 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.